Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04093167
Title Study of Molecular Response Adaptive Immuno-Chemotherapy in Patients With NSCLC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Canadian Cancer Trials Group
Indications

lung non-squamous non-small cell carcinoma

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
The Sidney Kimmel Comprehensive Cancer Centre Baltimore Maryland 21231 United States Details
BCCA - Vancouver Cancer Centre Vancouver British Columbia V5Z 4E6 Canada Details
Juravinski Cancer Centre at Hamilton Health Sciences Hamilton Ontario L8V 5C2 Canada Details
Kingston Health Sciences Centre Kingston Ontario K7L 2V7 Canada Details
Ottawa Hospital Research Institute Ottawa Ontario K1H 8L6 Canada Details
University Health Network Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field